Tertiary Prevention of HCC in Chronic Hepatitis B or C Infected Patients

SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) recurrence is the major obstacle concerning patients’ survival. Tertiary prevention by antiviral therapies could reduce HCC recurrence rate in both chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infected patients. In chronic hepatitis B (CHB...

Descripción completa

Detalles Bibliográficos
Autores principales: Teng, Wei, Liu, Yen-Chun, Jeng, Wen-Juei, Su, Chien-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038691/
https://www.ncbi.nlm.nih.gov/pubmed/33917345
http://dx.doi.org/10.3390/cancers13071729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038691/
https://www.ncbi.nlm.nih.gov/pubmed/33917345
http://dx.doi.org/10.3390/cancers13071729

Ejemplares similares